108 Once the therapeutic objective for an individual patient has been achieved, the dose should be reduced by 25 to 50% in order to maintain haemoglobin at that level.
Kui patsiendi jaoks on ravieesmärk saavutatud, tuleb annus vähendada 25 kuni 50%, et säilitada hemoglobiini sellel tasemel.